
What’s the latest in cancer treatment across Europe in early 2024 (1 Jan – 5 Mar 2024): Advancements, Innovations, Research, Awareness
(IN BRIEF) In early 2024, Europe’s medical and research communities announced major breakthroughs in cancer care, highlighting new treatments like AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan for lung and breast cancer, and AstraZeneca’s Tagrisso for EGFR-mutated lung cancer. Diagnostic advancements and genetic research promise more personalized and effective screening, particularly in breast and colorectal cancers. Efforts to raise awareness about cancer prevention and strategic initiatives to address cancer incidence were also emphasized. These developments mark significant progress in the fight against cancer, showcasing Europe’s leading role in oncology innovation.
Share the post "What’s new in cancer care across Europe in early 2024 (1 Jan – 5 Mar 2024): Advancements, Innovations, Research, Awareness"
(PRESS RELEASE) CAMBRIDGE, HELSINKI, BERLIN, ZURICH, 5-Mar-2024 — /EuropaWire/ — In the opening months of 2024 (1 Jan – 5 Mar 2024), European companies and institutions have made significant strides in the fight against cancer, unveiling a series of innovations and research findings that promise to transform the landscape of cancer care. This period witnessed a suite of innovations spanning novel therapeutic candidates, cutting-edge diagnostic tools, and insightful genetic studies, setting the stage for transformative shifts in cancer care dynamics and paving the way for more effective, personalized, and accessible cancer solutions.
The announcements made during the first two months of the year (2024) reveal significant advancements in cancer treatment, diagnostics, and research, emphasizing the ongoing efforts to combat this disease across various fronts:
Treatment, Diagnostic, Research, Awareness, etc.
- Treatment Advancements:
- AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan for lung and breast cancer.
- AstraZeneca’s Tagrisso for Stage III EGFR-mutated lung cancer and as a first-line treatment.
- BioNTech and Duality Biologics’ Phase 3 trial for a HER2-targeted therapy in breast cancer.
- Merck KGaA’s licensing agreement with Inspirna for a novel therapy for colorectal cancer.
- Diagnostic Innovations:
- Eckert & Ziegler’s collaboration with Novartis for neuroendocrine neoplasms diagnostics in Japan.
- Multi-cancer early detection (MCED) blood tests as highlighted by the Swiss Re Institute report.
- Genetic and Screening Research:
- University of Helsinki’s study on genetic risk information for breast cancer screening.
- University of Helsinki’s ReSisTrace methodology for identifying treatment-resistant cancer cells.
- University of Helsinki’s polygenic risk score for colorectal cancer.
- Awareness and Strategy:
- Aviva’s research on the need for increased cancer prevention awareness.
- University of Liverpool’s appointment of Professor Tim Maughan to combat cancer in the Liverpool City Region.
In more details:
A landmark development comes from AstraZeneca and Daiichi Sankyo with the EMA’s validation of marketing applications for datopotamab deruxtecan, targeting critical lung and breast cancer types. Similarly, AstraZeneca’s Tagrisso has showcased its potential in improving outcomes for lung cancer patients in advanced stages, further solidified by FDA’s nod for its use in a broader patient cohort.
In diagnostics, Eckert & Ziegler‘s alliance with Novartis Pharma K.K. shines light on [68Ga]Ga-DOTA-TATE PET/CT imaging’s role in enhancing neuroendocrine neoplasm diagnostics in Japan. Simultaneously, the advent of multi-cancer early detection (MCED) blood tests, as reported by the Swiss Re Institute, heralds a new era in cancer screening, promising a comprehensive and less invasive approach.
The genetic front sees the University of Helsinki making strides with studies suggesting a more nuanced breast cancer screening regime, informed by genetic risk profiles, and unveiling the ReSisTrace methodology to combat treatment-resistant cancer cells. This genetic lens also brings into focus the polygenic risk score by University of Helsinki for colorectal cancer, advocating for tailored screening strategies.
Amid these scientific and technological leaps, the narrative also weaves in the vital threads of awareness and strategic planning. Aviva’s research casts light on the gaps in public consciousness regarding cancer prevention, while the University of Liverpool‘s strategic appointment of Professor Tim Maughan aims to tackle cancer incidence head-on, particularly in underserved communities.
BioNTech‘s collaboration with Duality Biologics embarks on a pivotal trial for a novel HER2-targeted therapy in breast cancer, promising to widen the therapeutic landscape. Merck KGaA‘s venture with Inspirna introduces ompenaclid, a beacon of hope for colorectal cancer patients, marking another significant stride in cancer therapeutics.
As World Cancer Day (4 February) was commemorated, these announcements serve as a testament to the unwavering commitment of European companies and institutions to advancing cancer care. Through innovation, collaboration, and a deep-seated dedication to saving lives, the battle against cancer is being waged with renewed vigor and hope. Please also note that the announcements mentioned in this release include only the press releases that have been published on and sent out via EuropaWire during the following period: 1 Jan – 5 Mar 2024 and the information is certainly not exhaustive.
SOURCE: EuropaWire
- Patients as Partners® Europe Launches the 9th Annual Event with 2025 Keynotes, Featured Speakers and Topics
- eVTOLUTION: Pioneering the Future of Urban Air Mobility
- Reuters webinar: Effective Sustainability Data Governance
- Las acusaciones de fraude contra Ricardo Salinas no son nuevas: una perspectiva histórica sobre los problemas legales del multimillonario
- Digi Communications N.V. Announces the release of the Financial Calendar for 2025
- USA Court Lambasts Ricardo Salinas Pliego For Contempt Of Court Order
- 3D Electronics: A New Frontier of Product Differentiation, Thinks IDTechEx
- Ringier Axel Springer Polska Faces Lawsuit for Over PLN 54 million
- Digi Communications N.V. announces the availability of the report on corporate income tax information for the financial year ending December 31, 2023
- Unlocking the Multi-Million-Dollar Opportunities in Quantum Computing
- Digi Communications N.V. Announces the Conclusion of Facilities Agreements by Companies within Digi Group
- The Hidden Gem of Deep Plane Facelifts
- KAZANU: Redefining Naturist Hospitality in Saint Martin ↗️
- New IDTechEx Report Predicts Regulatory Shifts Will Transform the Electric Light Commercial Vehicle Market
- Almost 1 in 4 Planes Sold in 2045 to be Battery Electric, Finds IDTechEx Sustainable Aviation Market Report
- Digi Communications N.V. announces the release of Q3 2024 financial results
- Digi Communications NV announces Investors Call for the presentation of the Q3 2024 Financial Results
- Pilot and Electriq Global announce collaboration to explore deployment of proprietary hydrogen transport, storage and power generation technology
- Digi Communications N.V. announces the conclusion of a Memorandum of Understanding by its subsidiary in Romania
- Digi Communications N.V. announces that the Company’s Portuguese subsidiary finalised the transaction with LORCA JVCO Limited
- Digi Communications N.V. announces that the Portuguese Competition Authority has granted clearance for the share purchase agreement concluded by the Company’s subsidiary in Portugal
- OMRON Healthcare introduceert nieuwe bloeddrukmeters met AI-aangedreven AFib-detectietechnologie; lancering in Europa september 2024
- OMRON Healthcare dévoile de nouveaux tensiomètres dotés d’une technologie de détection de la fibrillation auriculaire alimentée par l’IA, lancés en Europe en septembre 2024
- OMRON Healthcare presenta i nuovi misuratori della pressione sanguigna con tecnologia di rilevamento della fibrillazione atriale (AFib) basata sull’IA, in arrivo in Europa a settembre 2024
- OMRON Healthcare presenta los nuevos tensiómetros con tecnología de detección de fibrilación auricular (FA) e inteligencia artificial (IA), que se lanzarán en Europa en septiembre de 2024
- Alegerile din Moldova din 2024: O Bătălie pentru Democrație Împotriva Dezinformării
- Northcrest Developments launches design competition to reimagine 2-km former airport Runway into a vibrant pedestrianized corridor, shaping a new era of placemaking on an international scale
- The Road to Sustainable Electric Motors for EVs: IDTechEx Analyzes Key Factors
- Infrared Technology Breakthroughs Paving the Way for a US$500 Million Market, Says IDTechEx Report
- MegaFair Revolutionizes the iGaming Industry with Skill-Based Games
- European Commission Evaluates Poland’s Media Adherence to the Right to be Forgotten
- Global Race for Autonomous Trucks: Europe a Critical Region Transport Transformation
- Digi Communications N.V. confirms the full redemption of €450,000,000 Senior Secured Notes
- AT&T Obtiene Sentencia Contra Grupo Salinas Telecom, Propiedad de Ricardo Salinas, Sus Abogados se Retiran Mientras Él Mueve Activos Fuera de EE.UU. para Evitar Pagar la Sentencia
- Global Outlook for the Challenging Autonomous Bus and Roboshuttle Markets
- Evolving Brain-Computer Interface Market More Than Just Elon Musk’s Neuralink, Reports IDTechEx
- Latin Trails Wraps Up a Successful 3rd Quarter with Prestigious LATA Sustainability Award and Expands Conservation Initiatives ↗️
- Astor Asset Management 3 Ltd leitet Untersuchung für potenzielle Sammelklage gegen Ricardo Benjamín Salinas Pliego von Grupo ELEKTRA wegen Marktmanipulation und Wertpapierbetrug ein
- Digi Communications N.V. announces that the Company’s Romanian subsidiary exercised its right to redeem the Senior Secured Notes due in 2025 in principal amount of €450,000,000
- Astor Asset Management 3 Ltd Inicia Investigación de Demanda Colectiva Contra Ricardo Benjamín Salinas Pliego de Grupo ELEKTRA por Manipulación de Acciones y Fraude en Valores
- Astor Asset Management 3 Ltd Initiating Class Action Lawsuit Inquiry Against Ricardo Benjamín Salinas Pliego of Grupo ELEKTRA for Stock Manipulation & Securities Fraud
- Digi Communications N.V. announced that its Spanish subsidiary, Digi Spain Telecom S.L.U., has completed the first stage of selling a Fibre-to-the-Home (FTTH) network in 12 Spanish provinces
- Natural Cotton Color lancia la collezione "Calunga" a Milano
- Astor Asset Management 3 Ltd: Salinas Pliego Incumple Préstamo de $110 Millones USD y Viola Regulaciones Mexicanas
- Astor Asset Management 3 Ltd: Salinas Pliego Verstößt gegen Darlehensvertrag über 110 Mio. USD und Mexikanische Wertpapiergesetze
- ChargeEuropa zamyka rundę finansowania, której przewodził fundusz Shift4Good tym samym dokonując historycznej francuskiej inwestycji w polski sektor elektromobilności
- Strengthening EU Protections: Robert Szustkowski calls for safeguarding EU citizens’ rights to dignity
- Digi Communications NV announces the release of H1 2024 Financial Results
- Digi Communications N.V. announces that conditional stock options were granted to a director of the Company’s Romanian Subsidiary
- Digi Communications N.V. announces Investors Call for the presentation of the H1 2024 Financial Results
- Digi Communications N.V. announces the conclusion of a share purchase agreement by its subsidiary in Portugal
- Digi Communications N.V. Announces Rating Assigned by Fitch Ratings to Digi Communications N.V.
- Digi Communications N.V. announces significant agreements concluded by the Company’s subsidiaries in Spain
- SGW Global Appoints Telcomdis as the Official European Distributor for Motorola Nursery and Motorola Sound Products
- Digi Communications N.V. announces the availability of the instruction regarding the payment of share dividend for the 2023 financial year
- Digi Communications N.V. announces the exercise of conditional share options by the executive directors of the Company, for the year 2023, as approved by the Company’s Ordinary General Shareholders’ Meetings from 18th May 2021 and 28th December 2022
- Digi Communications N.V. announces the granting of conditional stock options to Executive Directors of the Company based on the general shareholders’ meeting approval from 25 June 2024
- Digi Communications N.V. announces the OGMS resolutions and the availability of the approved 2023 Annual Report
- Czech Composer Tatiana Mikova Presents Her String Quartet ‘In Modo Lidico’ at Carnegie Hall
- SWIFTT: A Copernicus-based forest management tool to map, mitigate, and prevent the main threats to EU forests
- WickedBet Unveils Exciting Euro 2024 Promotion with Boosted Odds
- Museum of Unrest: a new space for activism, art and design
- Digi Communications N.V. announces the conclusion of a Senior Facility Agreement by companies within Digi Group
- Digi Communications N.V. announces the agreements concluded by Digi Romania (formerly named RCS & RDS S.A.), the Romanian subsidiary of the Company
- Green Light for Henri Hotel, Restaurants and Shops in the “Alter Fischereihafen” (Old Fishing Port) in Cuxhaven, opening Summer 2026
- Digi Communications N.V. reports consolidated revenues and other income of EUR 447 million, adjusted EBITDA (excluding IFRS 16) of EUR 140 million for Q1 2024
- Digi Communications announces the conclusion of Facilities Agreements by companies from Digi Group
- Digi Communications N.V. Announces the convocation of the Company’s general shareholders meeting for 25 June 2024 for the approval of, among others, the 2023 Annual Report
- Digi Communications NV announces Investors Call for the presentation of the Q1 2024 Financial Results
- Digi Communications intends to propose to shareholders the distribution of dividends for the fiscal year 2023 at the upcoming General Meeting of Shareholders, which shall take place in June 2024
- Digi Communications N.V. announces the availability of the Romanian version of the 2023 Annual Report
- Digi Communications N.V. announces the availability of the 2023 Annual Report
- International Airlines Group adopts Airline Economics by Skailark ↗️
- BevZero Spain Enhances Sustainability Efforts with Installation of Solar Panels at Production Facility
- Digi Communications N.V. announces share transaction made by an Executive Director of the Company with class B shares
- BevZero South Africa Achieves FSSC 22000 Food Safety Certification
- Digi Communications N.V.: Digi Spain Enters Agreement to Sell FTTH Network to International Investors for Up to EUR 750 Million
- Patients as Partners® Europe Announces the Launch of 8th Annual Meeting with 2024 Keynotes and Topics
- driveMybox continues its international expansion: Hungary as a new strategic location
- Monesave introduces Socialised budgeting: Meet the app quietly revolutionising how users budget
- Digi Communications NV announces the release of the 2023 Preliminary Financial Results
- Digi Communications NV announces Investors Call for the presentation of the 2023 Preliminary Financial Results
- Lensa, един от най-ценените търговци на оптика в Румъния, пристига в България. Първият шоурум е открит в София
- Criando o futuro: desenvolvimento da AENO no mercado de consumo em Portugal
- Digi Communications N.V. Announces the release of the Financial Calendar for 2024
- Customer Data Platform Industry Attracts New Participants: CDP Institute Report
- eCarsTrade annonce Dirk Van Roost au poste de Directeur Administratif et Financier: une décision stratégique pour la croissance à venir
- BevZero Announces Strategic Partnership with TOMSA Desil to Distribute equipment for sustainability in the wine industry, as well as the development of Next-Gen Dealcoholization technology
- Editor's pick archive....